|
|
 MeScore CRC
MeScore CRC is a groundbreaking solution for population-based eScreening and early detection of colorectal cancer.
Using patent-pending technology, MeScore performs risk stratification and calculates a personal risk score that
has proven a reliable indicator of the need for further testing. To calculate the score, Medial uses existing routine
lab results that are part of standard medical records, enabling screening of a substantial part of the population.
Solving the Compliance Challenge
MeScore CRC is a safe, simple method of detecting colorectal cancer that has the potential to dramatically increase
the coverage and compliance of population-based screening programs. Unlike other screening methods, MeScore is
a convenient, proactive approach that leverages existing and ongoing routine medical records.
eScreening is non-intrusive and easy both for the physician and the patient.
A Cost-Effective Approach
Through effective stratification of risk, MeScore supports better patient management and more efficient management
of healthcare resources at the level of the broader healthcare community. It employs robust models developed with
the Algomedical Platform to rapidly detect early signs of CRC. It gives healthcare organizations
the ability to significantly improve compliance, prevention and early detection in a very easy to implement method with
a low total cost of ownership.
MeScore CRC
Alternative screening methods in use today require specific physical tests, either of the colon itself, or via
proprietary stool or blood tests. Since patients perceive these tests to be intrusive or inconvenient, the compliance
levels are low and do not reach the goals set by most national and professional organizations. MeScore CRC, on the
other hand, is simple and cost effective to perform on a large part of the population. It serves as a very effective initial
eScreening technique that can enable health care organizations to better manage patients and available diagnosis
and treatment resources.
MeScore CRC has been validated in a collaborative project with a leading Israeli Health Management Organization
and is currently undergoing the regulatory approval process. To learn more about the solution, Contact Us.
|
